Screener
Corcept Therapeutics CORT Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Corcept Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: Corcept Therapeutics’s 10-Q, filed July 29, 2026. Open the filing →
- Filed
- Jul 29, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050613
FAQ
- What is Corcept Therapeutics's asset turnover?
- Corcept Therapeutics (CORT) reported asset turnover of 1× in Q2 2026.
- How has Corcept Therapeutics's asset turnover changed year-over-year?
- Corcept Therapeutics's asset turnover increased by 4.1% year-over-year, from 0.9× to 1×.
- What is the long-term trend for Corcept Therapeutics's asset turnover?
- Over 5 years (2020 to 2025), Corcept Therapeutics's asset turnover has grown at a 4.8% compound annual growth rate (CAGR), from 0.7× to 0.9×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about Corcept Therapeutics's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude